Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of KBP-V001 Influenza Vaccine in Healthy Adults
NCT04439695Phase 1Completed
- Sponsor
- KBio
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of KBP-V001 in influenza (4 arms), sponsored by KBio. Primary endpoints: Solicited administration site reactions at 7 days and Solicited systemic events at 7 days. Started Jun 2020; status: completed.
02
Drugs
KBP-V001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04439695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04439695.